Bupropion-Induced Tinnitus
The tinnitus is most likely caused by bupropion (Wellbutrin) itself, as tinnitus is a well-documented adverse effect of this medication, occurring in 2-6% of patients in clinical trials, with higher rates at increased doses.
Evidence from FDA Drug Labeling
The FDA-approved drug label for Wellbutrin explicitly lists tinnitus as a common adverse reaction 1:
- At 300 mg/day: Tinnitus occurred in 6% of patients vs. 2% with placebo
- At 400 mg/day: Tinnitus occurred in 6% of patients vs. 2% with placebo
- In Seasonal Affective Disorder trials: Tinnitus occurred in 3% of patients vs. <1% with placebo
This represents a 3-fold increase in tinnitus risk compared to placebo, establishing a clear dose-dependent relationship.
Clinical Characteristics of Bupropion-Induced Tinnitus
Based on the most recent case report 2, bupropion-induced tinnitus typically presents as:
- Bilateral low-pitched humming or ringing
- Onset after dose escalation (commonly when increasing from 150 mg to 300 mg daily)
- Reversible: Partial improvement with dose reduction, complete resolution after discontinuation
- No alternative causes: Normal audiometry, physical examination, and neuroimaging
The temporal relationship between dose escalation and symptom onset, combined with resolution after drug cessation, strongly supports causality 2.
Proposed Mechanism
The exact mechanism remains uncertain but likely involves altered dopaminergic or noradrenergic signaling within the auditory system 2. Bupropion is a norepinephrine-dopamine reuptake inhibitor, and these neurotransmitter systems play roles in auditory processing and tinnitus perception.
Clinical Management Algorithm
Immediate action:
- Confirm temporal relationship: Document when tinnitus started relative to bupropion initiation or dose increase
- Rule out other causes: Check for concurrent ototoxic medications, noise exposure, ear pathology, or hearing loss 3
- Assess severity and impact: Inquire about effects on sleep, concentration, and quality of life 3
Treatment approach:
- First step: Reduce bupropion dose to previous level where tinnitus was absent 2
- If partial improvement: Monitor for 1-2 weeks; may continue at lower dose if depression adequately controlled
- If no improvement or severe: Discontinue bupropion and switch to alternative antidepressant 2
- Alternative agents: Consider SSRIs (sertraline, escitalopram) which have lower tinnitus risk and may actually benefit some tinnitus patients 4, 5
Important Caveats
Do NOT:
- Continue escalating the dose hoping tinnitus will resolve—it typically worsens with higher doses 1
- Prescribe additional medications specifically to treat the tinnitus while continuing bupropion at the causative dose 6
- Order extensive neuroimaging unless other concerning neurological symptoms are present 6
Critical safety consideration: If the patient has significant depression or anxiety alongside tinnitus, assess for suicidal ideation, as suicide has been reported in patients with tinnitus and coexisting psychiatric illness 3. This requires prompt intervention regardless of the tinnitus etiology.
Prognosis
The tinnitus is completely reversible in most cases once bupropion is discontinued 2. Recovery may take days to weeks after cessation. This distinguishes drug-induced tinnitus from other forms of chronic tinnitus, which are typically permanent 3.